Health and Fitness Health and Fitness
Mon, November 29, 2010
[ Mon, Nov 29th 2010 ] - Market Wire
Orthofix International Announces Resignation of Thomas J. Kester From Board of Directors
[ Mon, Nov 29th 2010 ] - Market Wire
Cardiome to Present at Piper Jaffray Healthcare Conference
[ Mon, Nov 29th 2010 ] - Market Wire
Transgenomic, Inc. To Purchase Clinical Data, Inc.'s Diagnostic Business
[ Mon, Nov 29th 2010 ] - Market Wire
Humana Military Healthcare Services Announces New Disease Management Program for Depression
[ Mon, Nov 29th 2010 ] - Market Wire
Impax Laboratories Confirms Patent Suit Relating to Generic Concerta® 54 mg Tablets
[ Mon, Nov 29th 2010 ] - Market Wire
ANGIOTECH PHARMACEUTICALS ANNOUNCES PRIVATE LABEL PRODUCT SUPPLY AGREEMENT WITH HOLOGIC
[ Mon, Nov 29th 2010 ] - Market Wire
Apricus Biosciences Announces New NexACT® Transb .. hed in the International Journal of Pharmaceutics
[ Mon, Nov 29th 2010 ] - Market Wire
Imaging Diagnostic Systems Exhibits CT Laser Mamm .. 96th Annual Radiological Society of North Americ
[ Mon, Nov 29th 2010 ] - Market Wire
IDC LAUNCHES INTERNATIONAL VERSION OF ITS PROPRIETARY IMAGING SOFTWARE
[ Mon, Nov 29th 2010 ] - Market Wire
Sanofi Pasteur Starts a Phase II Vaccine Trial for Primary Prevention of Clostridium Difficile
[ Mon, Nov 29th 2010 ] - Market Wire
Seattle Genetics to Present at Piper Jaffray Health Care Conference
[ Mon, Nov 29th 2010 ] - Market Wire
Updated Clinical Data on ARIAD's Investigational .. nib, to Be Presented at Annual American Society o
[ Mon, Nov 29th 2010 ] - Market Wire
Oncolytics Biotech® Inc. Announces Publicati .. Results Examining Combination of REOLYSIN® a
[ Mon, Nov 29th 2010 ] - Market Wire
Teleflex Agrees to Sell Actuation Business
[ Mon, Nov 29th 2010 ] - Market Wire
Medisafe 1 Technologies Enters Discussions to Launch Pilot Project in Major Jerusalem Hospital
[ Mon, Nov 29th 2010 ] - Market Wire
AMAG Pharmaceuticals Announces Update to Feraheme® Label
[ Mon, Nov 29th 2010 ] - Market Wire
Affymax and Takeda Confirm U.S. Registration Stra .. , Hematidea"/Peginesatide, Following Meeting with
Thu, November 25, 2010
[ Thu, Nov 25th 2010 ] - Market Wire
CENTRIC HEALTH FILES MATERIAL CHANGE REPORT
[ Thu, Nov 25th 2010 ] - Market Wire
CHINA HEALTH LABS &; DIAGNOSTICS LTD. ANNOUNCES C .. NFERENCE CALL TO DISCUSS RESULTS OF THIRD QUARTER
Wed, November 24, 2010
[ Wed, Nov 24th 2010 ] - Market Wire
EGM International, Inc. (EGML) Announces the Sign .. t Regarding a Merger with GID Solutions Co., Ltd.
[ Wed, Nov 24th 2010 ] - Market Wire
Vertex Pharmaceuticals Announces Webcast of its P .. Piper Jaffray 22nd Annual Health Care Conference
[ Wed, Nov 24th 2010 ] - Market Wire
Angiotech Pharmaceuticals, Inc. Announces Commencement of Proceedings by Rex Medical LP
[ Wed, Nov 24th 2010 ] - Market Wire
Gilead Sciences presenta solicitud de nuevo frmac .. ara el r©gimen de una sola pastilla una vez al d
[ Wed, Nov 24th 2010 ] - Market Wire
Gilead Sciences dient nieuwe geneesmiddeltoepassi .. aal daagse behandeling met ©©n tablet Truvada®
[ Wed, Nov 24th 2010 ] - Market Wire
Somaxon Announces Closing of Public Offering of Common Stock
[ Wed, Nov 24th 2010 ] - Market Wire
Alexion to Present at the Piper Jaffray 22nd Annual Health Care Conference
[ Wed, Nov 24th 2010 ] - Market Wire
Alliance HealthCare Services to Present at the Piper Jaffray 22nd Annual Health Care Conference
[ Wed, Nov 24th 2010 ] - Market Wire
Sucampo Pharmaceuticals Invites Investors to Listen to Webcast from PiperJaffray Conference
[ Wed, Nov 24th 2010 ] - Market Wire
China Yongxin Pharmaceuticals Reports Third Quarter 2010 Results
[ Wed, Nov 24th 2010 ] - Market Wire
Affymax to Present at Piper Jaffray 22nd Annual Health Care Conference

Affymax to Present at Piper Jaffray 22nd Annual Health Care Conference


Published on 2010-11-24 05:05:41 - Market Wire
  Print publication without navigation


PALO ALTO, Calif.--([ BUSINESS WIRE ])--Affymax, Inc. (Nasdaq: AFFY) today announced that Arlene Morris, the company's chief executive officer, will present at the Piper Jaffray 22nd Annual Health Care Conference on Wednesday, December 1, 2010, at 2:00 p.m. Eastern time (11:00 a.m. Pacific time) at The New York Palace Hotel in New York City.

A live webcast of the presentation will be available on the investors section of the Company's website at [ www.affymax.com ]. A replay will also be available for 30 days following the presentation.

About Affymax, Inc.

Affymax, Inc. is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. For additional information, please visit [ www.affymax.com ].

Contributing Sources